Cardiovascular complications in covid-19 have been observed since the beginning of the pandemic, when a small study in Wuhan reported myocardial damage in a few patients. Studies later found that up to 30% of patients admitted to intensive care units had myocardial damage. Covid-19 is a vascular disease that appears to be respiratory because it is transmitted through the respiratory system, but much of the pathology takes place in the vascular system. It includes microvascular damage, thromboembolism, and dysregulated perfusion, which underlies the cardiac, pulmonary, and neurological manifestations of severe disease. The virus enters through the respiratory tract, but has systemic effects through blood vessels, which are the common denominator of complications in the brain, lungs, heart and kidneys. Acute heart damage occurred in 6-25% of admitted patients.